Separation of HIV-1 gag virus-like particles from vesicular particles impurities by hydroxyl-functionalized monoliths

J Sep Sci. 2017 Feb;40(4):979-990. doi: 10.1002/jssc.201600765. Epub 2017 Jan 20.

Abstract

The downstream processing of enveloped virus-like particles is very challenging because of the biophysical and structural similarity between correctly assembled particles and contaminating vesicular particles present in the feedstock. We used hydroxyl-functionalized polymethacrylate monoliths, providing hydrophobic and electrostatic binding contributions, for the purification of HIV-1 gag virus-like particles. The clarified culture supernatant was conditioned with ammonium sulfate and after membrane filtration loaded onto a 1 mL monolith. The binding capacity was 2 × 1012 /mL monolith and was only limited by the pressure drop. By applying either a linear or a step gradient elution, to decrease the ammonium sulfate concentration, the majority of double-stranded DNA (88-90%) and host cell protein impurities (39-61%) could be removed while the particles could be separated into two fractions. Proteomic analysis and evaluation of the p24 concentration showed that one fraction contained majority of the HIV-1 gag and the other fraction was less contaminated with proteins originated from intracellular compartments. We were able to process up to 92 bed volumes of conditioned loading material within 3 h and eluted in average 7.3 × 1011 particles per particle fraction, which is equivalent to 730 vaccination doses of 1 × 109 particles.

Keywords: hydrophobic interaction chromatography; mixed mode chromatography; monoliths; virus-like particles; viruses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Chemistry Techniques, Analytical / methods*
  • Gene Products, gag / isolation & purification*
  • Gene Products, gag / metabolism
  • HIV-1 / isolation & purification*
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Hydroxyl Radical / metabolism
  • Proteomics
  • Vaccines, Virus-Like Particle / isolation & purification

Substances

  • Gene Products, gag
  • Vaccines, Virus-Like Particle
  • Hydroxyl Radical